Here is some due diligence:$OMHE cheers, ticker symbol: $OMHE entity name: OMNIHEALTH, INC relivatrol physician endorsement: https://www.dailymotion.com/relivatrol/videos?sort=visited relivatrol study with larger ones underway: https://insights.ovid.com/obstetrics-gynecology/obsgy/2020/05/001/novel-therapeutic-management-post-episiotomy-pain/475/00006250 CONCLUSION: We concluded that Relivatrol© significantly decreases post-episiotomy pain. Being a pilot study had multiple limitations; we developed a protocol for a larger investigation and are currently collecting data involving a greater number of subjects, a control arm, pharmacokinetic parameters, and an analysis of quality of life impact. MY 35+ PAGE DUE DILIGENCE PACKET: https://docs.google.com/document/d/1ZGG-mpW3hHfFphRYBNx8o-uesfBgXjxFHYqhzcZmSqg/edit?usp=sharing OMNIHEALTH, INC DUE DILIGENCE